US 11395854
Trialkyl cationic lipids and methods of use thereof
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 11395854 (Trialkyl cationic lipids and methods of use thereof) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K38/00, A61K47/18